These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 9017775)
1. Pharmacists' ability to influence outcomes of hypertension therapy. Erickson SR; Slaughter R; Halapy H Pharmacotherapy; 1997; 17(1):140-7. PubMed ID: 9017775 [TBL] [Abstract][Full Text] [Related]
2. The impact of a multidisciplinary information technology-supported program on blood pressure control in primary care. Rinfret S; Lussier MT; Peirce A; Duhamel F; Cossette S; Lalonde L; Tremblay C; Guertin MC; LeLorier J; Turgeon J; Hamet P; Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):170-7. PubMed ID: 20031834 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Carter BL; Barnette DJ; Chrischilles E; Mazzotti GJ; Asali ZJ Pharmacotherapy; 1997; 17(6):1274-85. PubMed ID: 9399611 [TBL] [Abstract][Full Text] [Related]
4. Effect of pharmacist intervention on control of resistant hypertension. Morse GD; Douglas JB; Upton JH; Rodgers S; Gal P Am J Hosp Pharm; 1986 Apr; 43(4):905-9. PubMed ID: 3706334 [TBL] [Abstract][Full Text] [Related]
5. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"]. Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654 [TBL] [Abstract][Full Text] [Related]
6. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). McLean DL; McAlister FA; Johnson JA; King KM; Makowsky MJ; Jones CA; Tsuyuki RT; Arch Intern Med; 2008 Nov; 168(21):2355-61. PubMed ID: 19029501 [TBL] [Abstract][Full Text] [Related]
7. Self-monitoring of blood pressure promotes achievement of blood pressure target in primary health care. Halme L; Vesalainen R; Kaaja M; Kantola I; Am J Hypertens; 2005 Nov; 18(11):1415-20. PubMed ID: 16280273 [TBL] [Abstract][Full Text] [Related]
8. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study. Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006 [TBL] [Abstract][Full Text] [Related]
9. Effects of collaborative drug therapy management on patients' perceptions of care and health-related quality of life. Isetts BJ; Schondelmeyer SW; Heaton AH; Wadd WB; Hardie NA; Artz MB Res Social Adm Pharm; 2006 Mar; 2(1):129-42. PubMed ID: 17138505 [TBL] [Abstract][Full Text] [Related]
10. Pharmacist intervention program for control of hypertension. Chabot I; Moisan J; Grégoire JP; Milot A Ann Pharmacother; 2003 Sep; 37(9):1186-93. PubMed ID: 12921497 [TBL] [Abstract][Full Text] [Related]
11. Pharmacist involvement in primary care improves hypertensive patient clinical outcomes. Sookaneknun P; Richards RM; Sanguansermsri J; Teerasut C Ann Pharmacother; 2004 Dec; 38(12):2023-8. PubMed ID: 15522983 [TBL] [Abstract][Full Text] [Related]
12. Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice. Robinson JD; Segal R; Lopez LM; Doty RE Ann Pharmacother; 2010 Jan; 44(1):88-96. PubMed ID: 20040704 [TBL] [Abstract][Full Text] [Related]
13. [Improving blood pressure control with physician/pharmacist collaboration]. Carter BL Vnitr Lek; 2009 Apr; 55(4):389-94. PubMed ID: 19449756 [TBL] [Abstract][Full Text] [Related]
15. A multimodal blood pressure control intervention in 3 healthcare systems. Magid DJ; Ho PM; Olson KL; Brand DW; Welch LK; Snow KE; Lambert-Kerzner AC; Plomondon ME; Havranek EP Am J Manag Care; 2011 Apr; 17(4):e96-103. PubMed ID: 21774100 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [TBL] [Abstract][Full Text] [Related]
17. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367 [TBL] [Abstract][Full Text] [Related]
18. A comparison of home measurement and ambulatory monitoring of blood pressure in the adjustment of antihypertensive treatment. Niiranen TJ; Kantola IM; Vesalainen R; Johansson J; Ruuska MJ Am J Hypertens; 2006 May; 19(5):468-74. PubMed ID: 16647616 [TBL] [Abstract][Full Text] [Related]
19. Effect of patient withdrawal on a study evaluating pharmacist management of hypertension. Rozenfeld Y; Hunt JS Pharmacotherapy; 2006 Nov; 26(11):1565-71. PubMed ID: 17064200 [TBL] [Abstract][Full Text] [Related]
20. [Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program]. Tilly B; Guilhot J; Salanave B; Fender P; Allemand H Arch Mal Coeur Vaiss; 2002; 95(7-8):687-94. PubMed ID: 12365081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]